John Grundy Selected Research

Leiomyoma (Uterine Fibroids)

2/2009

Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Grundy Research Topics

Disease

2	Infections 01/2017 - 04/2009
1	COVID-19 12/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Obesity 01/2021
1	Stroke (Strokes) 01/2021
1	Pulmonary Arterial Hypertension 10/2019
1	Chronic Hepatitis C 01/2017
1	Meningoencephalitis 04/2009
1	Japanese Encephalitis 04/2009
1	Endometriosis 02/2009
1	Leiomyoma (Uterine Fibroids) 02/2009

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 12/2022 - 04/2009
1	CholesterolIBA 01/2021
1	ralinepagIBA 10/2019
1	ProstaglandinsIBA 10/2019
1	Epoprostenol ReceptorsIBA 10/2019
1	InterferonsIBA 01/2017
1	OligonucleotidesIBA 01/2017
1	temavirsen sodiumIBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2017
1	AcetylgalactosamineIBA 01/2017
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2009
1	Peptides (Polypeptides)IBA 02/2009

Therapy/Procedure

2	Therapeutics 01/2017 - 02/2009